Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Allscripts (MDRX – Research Report), Celestica (CLS – Research Report) and Citrix Systems (CTXS – Research Report).
RBC Capital analyst Sean Dodge maintained a Buy rating on Allscripts on April 29 and set a price target of $17.00. The company’s shares closed last Monday at $16.27, close to its 52-week high of $17.96.
According to TipRanks.com, Dodge is a 4-star analyst with an average return of 13.1% and a 57.5% success rate. Dodge covers the Technology sector, focusing on stocks such as Tabula Rasa HealthCare, Change Healthcare, and Health Catalyst.
Allscripts has an analyst consensus of Hold, with a price target consensus of $15.67, which is a -0.4% downside from current levels. In a report issued on April 29, Canaccord Genuity also maintained a Buy rating on the stock with a $18.00 price target.